1-4 of 4
M. Sue Leffell
Close
Sort by
Journal Articles

Desensitization for Mismatched Hematopoietic Stem Cell Transplantation (HSCT)

Douglas Edward Gladstone, MD, Andrea Zachary, Ephraim J. Fuchs, Leo Luznik, Yvette L. Kasamon, Richard J. Jones, M. Sue Leffell
Journal: Blood
Blood (2011) 118 (21): 1955.
https://doi.org/10.1182/blood.V118.21.1955.1955
Published: 2011
Journal Articles

Significance of Missing Inhibitory KIR Ligands in Nonmyeloablative, HLA-Haploidentical (Haplo) BMT with Posttransplantation High-Dose Cyclophosphamide (PT/Cy)

Yvette L. Kasamon, Leo Luznik, M. Sue Leffell, Hua-ling Tsai, Heather J. Symons, Javier Bolaños-Meade, Gary Rosner, Lawrence E. Morris, Pamela A. Crilley, Richard J. Jones, Ephraim J. Fuchs
Journal: Blood
Blood (2011) 118 (21): 840.
https://doi.org/10.1182/blood.V118.21.840.840
Published: 2011
Journal Articles

HLA-Haploidentical Bone Marrow Transplantation (BMT) for High Risk Hematologic Malignancies Using Myeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide

Heather Symons, MD, MHS, Allen R. Chen, MD, PhD, MHS, M. Sue Leffell, PhD, Marianna Zahurak, M.S., Kathy Schultz, Heather Karaszkiewicz, Leo Luznik, MD, Javier Bolanos Meade, MD, Yvette L. Kasamon, MD, Lode J. Swinnen, MD, Douglas Edward Gladstone, MD, Richard J. Jones, MD, Ephraim Fuchs, MD, MBA
Journal: Blood
Blood (2010) 116 (21): 2362.
https://doi.org/10.1182/blood.V116.21.2362.2362
Published: 2010
Journal Articles

Impact of Killer Immunoglobulin Receptor (KIR) Ligand Incompatibility in Nonmyeloablative Bone Marrow Transplantation (BMT) from Haploidentical Donors.

Heather J. Symons, MD, M. Sue Leffell, PhD, Nancy D. Rossiter, Elizabeth Sugar, PhD, Leo Luznik, MD, Michele Phelps, Angelita Crawford, M. Yair Levy, MD, Richard J. Jones, MD, Ephraim J. Fuchs, MD
Journal: Blood
Blood (2006) 108 (11): 604.
https://doi.org/10.1182/blood.V108.11.604.604
Published: 2006